Robyn Favinger, in Gothenburg, NE - Clinical Nurse Specialist

Robyn Favinger, is a Clinical Nurse Specialist - School based in Gothenburg, Nebraska. Robyn Favinger is licensed to practice in Nebraska (license number 16824) and her current practice location is 1322 Avenue I, Gothenburg, Nebraska. She can be reached at her office (for appointments etc.) via phone at (308) 537-3651.

NPI number for Robyn Favinger is 1043802788 and her current mailing address is 1322 Avenue I, Gothenburg, Nebraska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1043802788.

Contact Information

	Robyn Favinger,
	1322 Avenue I, Gothenburg, NE 69138-1815
	(308) 537-3651
	Not Available

Provider's Profile

Full Name	Robyn Favinger
Gender	Female
Speciality	Clinical Nurse Specialist - School
Location	1322 Avenue I, Gothenburg, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1043802788
Provider Enumeration Date: 02/04/2021
Last Update Date: 02/04/2021

Medical Identifiers

Medical identifiers for Robyn Favinger such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043802788	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
364SS0200X	Clinical Nurse Specialist - School	16824 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Robyn Favinger is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Robyn Favinger, 1322 Avenue I, Gothenburg, NE 69138-1815 Ph: (308) 537-3651	Robyn Favinger, 1322 Avenue I, Gothenburg, NE 69138-1815 Ph: (308) 537-3651

News Archive

BioMimetic reports final study results comparing Augment Bone Graft to autograft in foot, ankle fusion surgery

BioMimetic Therapeutics will report today the final, one year results of its North American Pivotal Study comparing Augment Bone Graft to autograft in foot and ankle fusion surgery. The presentation of the data by Dr. Timothy Daniels, associate professor of orthopedic surgery at the University of Toronto and St. Michaels Hospital, will take place at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting.

Pain monitoring technology can reduce intraoperative opioid consumption

A new study has shown that effective opioid-sparing anaesthesia with dexmedetomidine can be guided with NOL pain monitoring technology (Medasense, Israel). The study showed that the NOL monitor is able to detect the effect of dexmedetomidine on the patient's pain response and enable administration of less intraoperative opioids.

Tracking tau protein yields insight into possible treatments for neurodegenerative diseases

In the fight against neurodegenerative diseases such as frontotemporal dementia, Alzheimer's and Chronic Traumatic Encephalopathy, the tau protein is a major culprit.

Antisocial behaviour in boys leads to poor health in men

A study of over 500 men born in the early 70s in Dunedin reveals that the costs associated with antisocial behaviour may be much higher than previously thought. The research led by scientists from the MRC Social, Genetic and Developmental Psychiatry Centre based at the Institute of Psychiatry, King's College London is published in Archives of General Psychiatry.

Robyn Favinger, - Clinical Nurse Specialist in Gothenburg, NE